Literature DB >> 31102313

Establishment of an International Reference Reagent for standardization of von Willebrand factor binding to recombinant glycoprotein Ib (VWF:GPIbM and VWF:GPIbR): Official Communication of the SSC.

Anthony R Hubbard1, Sandra L Haberichter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31102313      PMCID： PMC7051102          DOI： 10.1111/jth.14429

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

1.  Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316).

Authors:  A R Hubbard; M Hamill; M Beeharry; S A Bevan; A B Heath
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

Review 2.  Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.

Authors:  G Castaman; A Hillarp; A Goodeve
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

Review 3.  Diagnostic approach to von Willebrand disease.

Authors:  Christopher Ng; David G Motto; Jorge Di Paola
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

Review 4.  Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.

Authors:  I Bodó; J Eikenboom; R Montgomery; J Patzke; R Schneppenheim; J Di Paola
Journal:  J Thromb Haemost       Date:  2015-05-09       Impact factor: 5.824

5.  Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

Authors:  Veronica H Flood; Joan Cox Gill; Patricia A Morateck; Pamela A Christopherson; Kenneth D Friedman; Sandra L Haberichter; Raymond G Hoffmann; Robert R Montgomery
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

6.  von Willebrand factor standards for plasma and concentrate testing.

Authors:  Anthony R Hubbard
Journal:  Semin Thromb Hemost       Date:  2006-07       Impact factor: 4.180

7.  Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.

Authors:  Emmanuel J Favaloro; Soma Mohammed
Journal:  Thromb Res       Date:  2015-12-17       Impact factor: 3.944

8.  A comparative evaluation of a new automated assay for von Willebrand factor activity.

Authors:  A S Lawrie; F Stufano; M T Canciani; I J Mackie; S J Machin; F Peyvandi
Journal:  Haemophilia       Date:  2012-12-04       Impact factor: 4.287

9.  Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.

Authors:  Juergen Patzke; Ulrich Budde; Andreas Huber; Adriana Méndez; Heidrun Muth; Tobias Obser; Ellinor Peerschke; Matthias Wilkens; Reinhard Schneppenheim
Journal:  Blood Coagul Fibrinolysis       Date:  2014-12       Impact factor: 1.276

10.  Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.

Authors:  Emmanuel J Favaloro; Soma Mohammed
Journal:  Thromb Res       Date:  2014-09-28       Impact factor: 3.944
View more
  1 in total

1.  Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.

Authors:  Margaret V Ragni
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.